{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 9.512691576674115e-06, "B": 5.9604641222676946e-08, "C": 1.311300820816541e-06, "D": 0.8508172631263733, "E": 0.0}, "ranked_options": [{"letter": "E", "text": "Doxorubicin", "avg_nll": 0.0}, {"letter": "B", "text": "Rituximab", "avg_nll": 5.9604641222676946e-08}, {"letter": "C", "text": "Cyclophosphamide", "avg_nll": 1.311300820816541e-06}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 9.512691576674115e-06}, {"letter": "D", "text": "Vincristine", "avg_nll": 0.8508172631263733}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 4.0837483406066895, "B": 1.1508127450942993, "C": 1.4519277811050415, "D": 2.312255859375, "E": 3.0961310863494873}, "ranked_options": [{"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 1.1508127450942993}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 1.4519277811050415}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 2.312255859375}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 3.0961310863494873}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 4.0837483406066895}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 5.0067219734191895, "B": Infinity, "C": Infinity, "D": 13.307350158691406, "E": 4.057666778564453}, "ranked_options": [{"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 4.057666778564453}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 5.0067219734191895}, {"letter": "D", "text": "Brain abscess", "avg_nll": 13.307350158691406}, {"letter": "B", "text": "Dementia", "avg_nll": null}, {"letter": "C", "text": "Parkinson", "avg_nll": null}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 3.6889290809631348, "B": 2.9854445457458496, "C": 4.930721759796143, "D": 6.40355920791626, "E": 5.977105140686035}, "ranked_options": [{"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 2.9854445457458496}, {"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 3.6889290809631348}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 4.930721759796143}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 5.977105140686035}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 6.40355920791626}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 8.279568672180176, "B": 9.317800521850586, "C": 8.659923553466797, "D": 3.8913803100585938, "E": 8.149895668029785}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 3.8913803100585938}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 8.149895668029785}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 8.279568672180176}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 8.659923553466797}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 9.317800521850586}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 5.697237491607666, "B": 5.697237491607666, "C": 1.3577933311462402, "D": 3.557793378829956, "E": 4.35779333114624}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 1.3577933311462402}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 3.557793378829956}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 4.35779333114624}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 5.697237491607666}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 5.697237491607666}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 6.164714813232422, "B": 6.729528427124023, "C": 3.928375720977783, "D": 6.745781898498535, "E": 7.8077545166015625}, "ranked_options": [{"letter": "C", "text": "Optiray 320", "avg_nll": 3.928375720977783}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 6.164714813232422}, {"letter": "B", "text": "Imeron 400", "avg_nll": 6.729528427124023}, {"letter": "D", "text": "Gadovist", "avg_nll": 6.745781898498535}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 7.8077545166015625}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 4.806191444396973, "B": 3.8520822525024414, "C": 5.0442986488342285, "D": 6.045334815979004, "E": 5.192254543304443}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 3.8520822525024414}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 4.806191444396973}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 5.0442986488342285}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 5.192254543304443}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 6.045334815979004}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 3.9963483810424805, "B": 5.433726787567139, "C": 2.086907148361206, "D": 4.205883979797363, "E": 5.50764799118042}, "ranked_options": [{"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 2.086907148361206}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 3.9963483810424805}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 4.205883979797363}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 5.433726787567139}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 5.50764799118042}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 3.7261030673980713, "B": 3.5336239337921143, "C": 3.701079845428467, "D": 3.2042839527130127, "E": 3.546879291534424}, "ranked_options": [{"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 3.2042839527130127}, {"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 3.5336239337921143}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 3.546879291534424}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 3.701079845428467}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 3.7261030673980713}], "correct_answer_letter": "B", "error": null, "method": "local"}
